Anika Therapeutics (ANIK) EPS (Basic) Growth (3y) (2013 - 2025)
Anika Therapeutics (ANIK) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | 49.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.11% |
| Sep 30, 2025 | 30.17% |
| Jun 30, 2025 | 30.87% |
| Mar 31, 2025 | 31.72% |
| Dec 31, 2024 | -80.31% |
| Sep 30, 2024 | -272.51% |
| Jun 30, 2024 | -28.58% |
| Mar 31, 2024 | -42.27% |
| Dec 31, 2023 | 44.24% |
| Sep 30, 2023 | 0.33% |
| Jun 30, 2023 | 29.94% |
| Mar 31, 2023 | -55.11% |
| Dec 31, 2022 | 16.17% |
| Sep 30, 2022 | -34.55% |
| Jun 30, 2022 | -31.77% |
| Mar 31, 2022 | -38.08% |
| Dec 31, 2021 | -33.64% |
| Sep 30, 2021 | -58.46% |
| Jun 30, 2021 | -12.99% |
| Mar 31, 2021 | 34.52% |